Journal of Literature Pharmacy Sciences

İlaç Fiyatlandırma Yöntemleri ve Dünyadan Türkiye'ye Bir Yansıma: Geleneksel Derleme
Pharmaceutical Pricing Methods and a Reflection from World to Türkiye: Traditional Review
Ebru ERDAĞa , Leyla YUMRUKAYAa , Selen YEĞENOĞLUa
aHacettepe Üniversitesi Eczacılık Fakültesi, Eczacılık İşletmeciliği ABD, Ankara, Türkiye
J Lit Pharm Sci. 2023;12(3):201-9
doi: 10.5336/pharmsci.2023-98571
Article Language: TR
Full Text
ÖZET
Sağlık hizmetleri sunumuna ayrılan kaynakların, etkili ve verimli bir şekilde kullanılmasını araştıran sağlık ekonomisinin bir alt disiplini olan ilaç ekonomisi, ilaçlar için ayrılan kaynakların verimli kullanımını araştırmaktadır. Bu noktada, ilaçların fiyatlandırılmasında kullanılan yöntemler ve politikalar, sağlık hizmetleri sunumu için ayrılan kaynaklara doğrudan etki etmektedir. İlaç fiyatlandırılmasında dış referans fiyat, iç referans fiyat, değer-bazlı fiyatlandırma, kar marjı düzenlemeleri, fiyat müzakereleri, jenerik ve biyobenzer ilaçların kullanımının teşvik edilmesi, toplu alımlar, maliyete dayalı fiyatlandırma ve vergi düzenlemeleri gibi çeşitli yaklaşımlarla, ilaç maliyetlerinin kontrol altına alınması amaçlanmaktadır. Ülkeler; pazar durumu, demografik ve ekonomik özellikler gibi koşullarını göz önünde bulundurarak, bu yaklaşımlardan bir veya birkaçını bir arada uygulayabilmektedir. Türkiye'de ilaç fiyatlandırması, fiyat kararnameleri doğrultusunda gerçekleşmektedir. 1956 yılından başlamak üzere, birçok ilaç fiyat kararnamesi yayımlanmış, bu kararnameler tebliğler ile de destek desteklenmiştir. Zaman içerisinde birçok değişiklik olmuş, kar marjı düzenlemeleri ile başlayan uygulamalar günümüzde referans fiyatlandırma sistemi ve müzakere yaklaşımları ile devam etmektedir. Ancak her yaklaşım, avantajları ile birlikte dezavantajlar da getirmektedir. Bu bağlamda, referans fiyatlandırma yaklaşımı ile dünyadaki gelişmeler daha yakından takip edilmekte iken aynı zamanda referans ülkelerdeki ekonomik durum, kişi başı gelir düzeyi ve sağlık politikalarının farklı olması gibi nedenlerle kısıtlamalar ortaya çıkabilmektedir. Sağlık hizmetlerine ve ilaçlara erişim, sağlık hizmeti sunumunda kritik önem taşımaktadır. Bu kapsamda, bu çalışmada, ilaç fiyatlandırılmasında uygulanan çeşitli yöntemler, dünyadan örnekler ve ülkemizdeki uygulamalar bağlamında değerlendirilmiştir.

Anahtar Kelimeler: Farmakoekonomi; ilaç fiyatlandırma; ilaç fiyatlandırma yöntemleri; sağlık ekonomisi; sağlık harcamaları
ABSTRACT
Pharmacoeconomics is a sub-discipline of health economics. And health economics focuses on the effective and efficient use of resources allocated for health services. Similarly, pharmacoeconomics focuses on the efficient use of resources allocated for pharmaceuticals. In this regard, the techniques and policies available for the pricing of pharmaceuticals directly affect the resources allocated for health services. Various approaches such as external reference pricing, internal reference pricing, value-based pricing, profit margin regulations, price negotiations, encouraging the use of generic and biosimilar medicines, pooled procurement, cost-plus pricing and tax regulations are used in order to control drug costs. Countries may apply one or a combination of these approaches, considering their conditions such as market position, demographic and economic characteristics. Drug pricing in Turkey is realised in line with price decrees. Starting from 1956, many drug price decrees were issued and these decrees were supported by communiqués. There have been many changes over time, and practices those started with profit margin regulations continue today with the reference pricing system and negotiation approaches. Yet, each approach brings disadvantages as well as advantages. In this context, while the reference pricing approach allows to follow-up global developments, it can also lead to limitations due to different economic conditions, income levels and health policies in the reference countries. Access to health services and pharmaceuticals has a critical importance in health service provision. Thus, in this study, various methods applied to pharmaceutical pricing are evaluated in the context of examples worldwide and practices in Türkiye.

Keywords: Pharmacoeconomics; pharmaceutical pricing; pharmaceutical pricing methods; health economics; health expenditure
REFERENCES:
  1. Listl S, Grytten JI, Birch S. What is health economics? Community Dent Health. 2019;36(4):262-74. [PubMed] 
  2. Rexford E. Santerre SPN. Health Economics Theories, Insights and Industry Studies. 5th ed. Ohio: South-Western, Cengage Learning; 2010.
  3. Culyer AJ, Newhouse JP. Handbook of Health Economics. 1st ed. New York: Elsevier; 2000. [Crossref] 
  4. Arenas-Guzman R, Tosti A, Hay R, Haneke E; National Institue for Clinical Excellence. Pharmacoeconomics--an aid to better decision-making. J Eur Acad Dermatol Venereol. 2005;19 Suppl 1:34-9. [Crossref]  [PubMed] 
  5. Barber N. Regulating pharmaceuticals in Europe: striving for efficiency, equity and quality. Quality and Safety in Health Care. 2001;14(3):227-8. [Crossref]  [PMC] 
  6. Stargardt T, Vandoros S. Pharmaceutical pricing and reimbursement regulation in Europe. In: Culyer AJ, ed. Encyclopedia of Health Economics. 1st ed. Waltham: Elsevier; 2014. p.29-36. [Crossref] 
  7. World Health Organization. WHO Guideline on Country Pharmaceutical Pricing Policies. Geneva: World Health Organization; 2020. [Link] 
  8. Rémuzat C, Urbinati D, Mzoughi O, El Hammi E, Belgaied W, Toumi M. Overview of external reference pricing systems in Europe. J Mark Access Health Policy. 2015;3. [Crossref]  [PubMed]  [PMC] 
  9. Ruggeri K, Nolte E. Pharmaceutical pricing: the use of external reference pricing. Rand Health Q. 2013;3(2):6. [PubMed]  [PMC] 
  10. Kang SY, Bai G, DiStefano MJ, Socal MP, Yehia F, Anderson GF. Comparative approaches to drug pricing. Annu Rev Public Health. 2020;41:499-512. [Crossref]  [PubMed] 
  11. Yalçın Balçık P, Karsavuran S. Dünyada ve Türkiye'de ilaç fiyatlandırması [Pharmaceutical pricing in the world and Turkey]. Hacettepe Sağlık İdaresi Dergisi. 2012;15(2):38-67. [Link] 
  12. Kanavos P, Üstel İ, Costa-Font J. Türkiye'de İlaç Geri Ödeme Politikası. İstanbul: Sağlıkta Umut Vakfı (SUVAK); 2005. [Link] 
  13. Çalışkan Z. Referans fiyat ve ilaç piyasası [Reference pricing and pharmacutical market]. Hacettepe Sağlık İdaresi Dergisi. 2008;11(1):49-75. [Link] 
  14. Jommi C, Armeni P, Costa F, Bertolani A, Otto M. Implementation of value-based pricing for medicines. Clin Ther. 2020;42(1):15-24. [Crossref]  [PubMed] 
  15. Lee KS, Kassab YW, Taha NA, Zainal ZA. Factors impacting pharmaceutical prices and affordability: narrative review. Pharmacy (Basel). 2020;9(1):1. [Crossref]  [PubMed]  [PMC] 
  16. Garattini L, Finazzi B, Mannucci PM. Pharmaceutical pricing in Europe: time to take the right direction. Intern Emerg Med. 2022;17(4):945-8. [Crossref]  [PubMed] 
  17. Cameron A, Mantel-Teeuwisse AK, Leufkens HG, Laing RO. Switching from originator brand medicines to generic equivalents in selected developing countries: how much could be saved? Value Health. 2012;15(5):664-73. [Crossref]  [PubMed] 
  18. Huff-Rousselle M. The logical underpinnings and benefits of pooled pharmaceutical procurement: a pragmatic role for our public institutions? Soc Sci Med. 2012;75(9):1572-80. [Crossref]  [PubMed] 
  19. Khoso I, Ahmed RR, Ahmed J. Pricing strategies in pharmaceutical marketing. The Pharma Innovation Journal. 2014;3(7):13-7. [Link] 
  20. Lee KS, Kassab YW, Taha NA, Zainal ZA. A systematic review of pharmaceutical price mark-up practice and its implementation. Explor Res Clin Soc Pharm. 2021;2:100020. [Crossref]  [PubMed]  [PMC] 
  21. Wertheimer AI, Grumer SK. Overview of international pharmacy pricing. Pharmacoeconomics. 1992;2(6):449-55. [Crossref]  [PubMed] 
  22. Vogler S, Habl C, Bogut M, Voncina L. Comparing pharmaceutical pricing and reimbursement policies in Croatia to the European Union Member States. Croat Med J. 2011;52(2):183-97. [Crossref]  [PubMed]  [PMC] 
  23. Atikeler EK, Özçelikay G. Comparison of pharmaceutical pricing and reimbursement systems in Turkey and certain EU countries. Springerplus. 2016;5(1):1876. [Crossref]  [PubMed]  [PMC] 
  24. Mossialos E, Mrazek M. Regulating pharmaceutical prices in the European Union. Regulating Pharmaceuticals in Europe: Striving for Efficiency, Equity and Quality. 1st ed. Berkshire: Open University Press; 2004. p.114-29.
  25. Rovira J. Standardization of the economic evaluation of health technologies. European developments. Med Care. 1996;34(12 Suppl):DS182-8. [PubMed] 
  26. Darbà J. Pharmaceutical expenditure in Spain: evolution and cost containment measures during 1998-2001. Eur J Health Econ. 2003;4(3):151-7. [Crossref]  [PubMed] 
  27. Yfantopoulos J. Pharmaceutical pricing and reimbursement reforms in Greece. Eur J Health Econ. 2008;9(1):87-97. [Crossref]  [PubMed] 
  28. Rodwin MA. Pharmaceutical price and spending controls in France: lessons for the United States. Int J Health Serv. 2020;50(2):156-65. [Crossref]  [PubMed] 
  29. Folino-Gallo P, Montilla S, Bruzzone M, Martini N. Pricing and reimbursement of pharmaceuticals in Italy. Eur J Health Econ. 2008;9(3):305-10. [Crossref]  [PubMed] 
  30. Mrazek MF. Comparative approaches to pharmaceutical price regulation in the European Union. Croat Med J. 2002;43(4):453-61. [PubMed] 
  31. Ekelund M, Persson B. Pharmaceutical pricing in a regulated market. Review of Economics and Statistics. 2003;85(2):298-306. [Crossref] 
  32. Moïse P, Docteur E. Pharmaceutical Pricing and Reimbursement Policies in Sweden. OECD Health Working Papers No. 28. 2007. [Crossref] 
  33. Rinta S. Pharmaceutical pricing and reimbursement in Finland. The European Journal of Health Economics (HEPAC). 2001;2(3):128-35. [Crossref] 
  34. Wertheimer A, Huang M. The healthcare system and pharmaceutical prices in United States. In: Babar ZUD, ed. Pharmaceutical Prices in the 21st Century. 1st ed. Cham: Springer International Publishing; 2015. p.309-19 [Crossref] 
  35. Verghese NR, Barrenetxea J, Bhargava Y, Agrawal S, Finkelstein EA. Government pharmaceutical pricing strategies in the Asia-Pacific region: an overview. J Mark Access Health Policy. 2019;7(1):1601060. [Crossref]  [PubMed]  [PMC] 
  36. Takayama A, Narukawa M. Pharmaceutical pricing and reimbursement in Japan: for faster, more complete access to new drugs. Ther Innov Regul Sci. 2016;50(3):361-7. [Crossref]  [PubMed] 
  37. Hu J, Mossialos E. Pharmaceutical pricing and reimbursement in China: when the whole is less than the sum of its parts. Health Policy. 2016;120(5):519-34. [Crossref]  [PubMed] 
  38. Vitry AI, Thai L, Roughead EE. Pharmaceutical pricing policies in Australia. In: Babar ZUD, ed. Pharmaceutical Prices in the 21st Century. 1st ed. Cham: Springer International Publishing; 2015. p.1-23. [Crossref] 
  39. Sönmez S, İlgün G. Türkiye'de ilaç fiyatlandırma ve geri ödeme politikalarının AB ülkeleri ile karşılaştırılması [Comparison of drug pricing and reimbursement policies in Turkey with EU countries]. Sayıştay Dergisi. 2018;108:99-121. [Link] 
  40. Karakoç HD. İlaç sektöründe fiyat rekabeti [Uzmanlık tezi]. Ankara: Rekabet Kurumu; 2005. Erişim tarihi: 22.05.2023. [Link] 
  41. Kumru S, Top M. İlaç fiyatlandırma ve geri ödeme politikalarının orijinal ilaç ve jenerik ilaç açısından değerlendirilmesi: hipertansiyon ilaçları örneği [Evaluation of pharmaceutical pricing and reimbursement policies with regard to original drug and generic drug: a case of hypertension drugs]. Hacettepe Sağlık İdaresi Dergisi. 2017;20(2):179-201. [Link] 
  42. Resmî Gazete (30.06.2007, Sayı: 26568) Beşeri İlaçların Fiyatlandırılmasına Dair Karar; 2007. Erişim tarihi: 14.06.2023 [Link] 
  43. Türkiye İlaç ve Tıbbi Cihaz Kurumu [İnternet]. [Erişim tarihi: 10 Haziran 2023]. Türkiye İlaç ve Tıbbi Cihaz Kurumu Tarihçesi. Erişim linki: [Link] 
  44. Doğan NB. Reflections of the global implementation of intellectual property rights on pharmaceutical policies: the case of Turkey [Master thesis]. İstanbul: Boğaziçi University; 2012. Erişim tarihi: 25.05.2023 [Link] 
  45. Resmî Gazete (25.11.2004, Sayı: 25651) Beşeri Tıbbi Ürünlerin Fiyatlandırılmasına Dair Kararda Değişiklik Yapılmasına Dair Karar; 2004. Erişim tarihi: 14.06.2023 [Crossref] 
  46. Resmî Gazete (10.07.2015, Sayı: 29412) Beşeri Tıbbi Ürünlerin Fiyatlandırılmasına Dair Karar; 2015. Erişim tarihi: 14.06.2023 [Link] 
  47. Resmî Gazete (12.10.2022, Sayı: 31981). Beşeri Tıbbi Ürünlerin Fiyatlandırılmasına Dair Kararda Değişiklik Yapılması Hakkında Karar; 2022. Erişim tarihi: 16.05.2023. [Link] 
  48. Resmî Gazete (14.12.2022, Sayı: 32043) Beşeri Tıbbi Ürünlerin Fiyatlandırılmasına Dair Kararda Değişiklik Yapılması Hakkında Karar; 2022. Erişim tarihi: 15.05.2023 [Link] 
  49. Resmî Gazete (14.03.2023, Sayı: 32132). Beşeri Tıbbi Ürünlerin Fiyatlandırılmasına Dair Kararda Değişiklik Yapılması Hakkında Karar; 2023. Erişim tarihi: 14.05.2023 [Link] 
  50. Resmî Gazete (23.07.2023, Sayı: 32257) Beşeri Tıbbi Ürünlerin Fiyatlandırılmasına Dair Kararda Değişiklik Yapılması Hakkında Karar; 2023. Erişim tarihi: 24.07.2023 [Link] 

.: Up To Date

.: Process List

Login



Contact


Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş.

.: Address

Turkocagi Caddesi No:30 06520 Balgat / ANKARA
Phone: +90 312 286 56 56
Fax: +90 312 220 04 70
E-mail: info@turkiyeklinikleri.com

.: Manuscript Editing Department

Phone: +90 312 286 56 56/ 2
E-mail: yaziisleri@turkiyeklinikleri.com

.: English Language Redaction

Phone: +90 312 286 56 56/ 145
E-mail: tkyayindestek@turkiyeklinikleri.com

.: Marketing Sales-Project Department

Phone: +90 312 286 56 56/ 142
E-mail: reklam@turkiyeklinikleri.com

.: Subscription and Public Relations Department

Phone: +90 312 286 56 56/ 118
E-mail: abone@turkiyeklinikleri.com

.: Customer Services

Phone: +90 312 286 56 56/ 118
E-mail: satisdestek@turkiyeklinikleri.com

1. TERMS OF USE

1.1. To use the web pages with http://www.turkiyeklinikleri.com domain name or the websites reached through the sub domain names attached to the domain name (They will be collectively referred as "SITE"), please read the conditions below. If you do not accept these terms, please cease to use the "SITE." "SITE" owner reserves the right to change the information on the website, forms, contents, the "SITE," "SITE" terms of use anytime they want.

1.2. The owner of the "SITE" is Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. (From now on it is going to be referred as "Turkiye Klinikleri", shortly) and it resides at Turkocagi cad. No:30, 06520 Balgat Ankara. The services in the "SITE" are provided by "Turkiye Klinikleri."

1.3. Anyone accessing the "SITE" with or without a fee whether they are a natural person or a legal identity is considered to agree these terms of use. In this contract hereby, "Turkiye Klinikleri" may change the stated terms anytime. These changes will be published in the "SITE" periodically and they will be valid when they are published. Any natural person or legal identity benefiting from and reaching to the "SITE" are considered to be agreed to any change on hereby contract terms done by "Turkiye Klinikleri."

1.4. The "Terms of Use" hereby is published in the website with the last change on March 30th 2014 and the "SITE" is activated by enabling the access to everyone. The "Terms of Use" hereby is also a part of the any "USER Contract" was and/or will be done with the users using "Turkiye Klinikleri" services with or without a fee an inseparable.

2. DEFINITIONS

2.1. "SITE": A website offering different kind of services and context with a certain frame determined by "Turkiye Klinikleri" and it is accessible on-line on http://www.turkiyeklinikleri.com domain name and/or subdomains connected to the domain name.

2.2. USER: A natural person or a legal identity accessing to the "SITE" through online settings.

2.3. LINK: A link enabling to access to another website through the "SITE", the files, the context or through another website to the "SITE", the files and the context.

2.4. CONTEXT: Any visual, literary and auditory images published in the "Turkiye Klinikleri", "SITE" and/or any website or any accessible information, file, picture, number/figures, price, etc.

2.5. "USER CONTRACT": An electronically signed contract between a natural or a legal identity benefiting from special services "Turkiye Klinikleri" will provide and "Turkiye Klinikleri".

3. SCOPE OF THE SERVICES

3.1. "Turkiye Klinikleri" is completely free to determine the scope and quality of the services via the "SITE".

3.2. To benefit the services of "Turkiye Klinikleri" "SITE", the "USER" must deliver the features that will be specified by "Turkiye Klinikleri". "Turkiye Klinikleri" may change this necessity any time single-sided.

3.3. Not for a limited number, the services "Turkiye Klinikleri" will provide through the "SITE" for a certain price or for free are;

- Providing scientific articles, books and informative publications for health industry.

- Providing structural, statistical and editorial support to article preparation stage for scientific journals.

4. GENERAL PROVISIONS

4.1. "Turkiye Klinikleri" is completely free to determine which of the services and contents provided in the "SITE" will be charged.

4.2. People benefiting from the services provided by "Turkiye Klinikleri" and using the website can use the "SITE" only according to the law and only for personal reasons. Users have the criminal and civil liability for every process and action they take in the "SITE". Every USER agrees, declares and undertakes that they will not proceed by any function or action infringement of rights of "Turkiye Klinikleri"s and/or other third parties', they are the exclusive right holder on usage, processing, storage, made public and revealing any written, visual or auditory information reported to Turkiye Klinikleri" and/or "SITE" to the third parties. "USER" agrees and undertakes that s/he will not duplicate, copy, distribute, process, the pictures, text, visual and auditory images, video clips, files, databases, catalogs and lists within the "SITE", s/he will not be using these actions or with other ways to compete with "Turkiye Klinikleri", directly or indirectly.

4.3. The services provided and the context published within the "SITE" by third parties is not under the responsibility of "Turkiye Klinikleri", institutions collaborated with "Turkiye Klinikleri", "Turkiye Klinikleri" employee and directors, "Turkiye Klinikleri" authorized salespeople. Commitment to accuracy and legality of the published information, context, visual and auditory images provided by any third party are under the full responsibility of the third party. "Turkiye Klinikleri" does not promise and guarantee the safety, accuracy and legality of the services and context provided by a third party.

4.4. "USER"s cannot act against "Turkiye Klinikleri", other "USER"s and third parties by using the "SITE". "Turkiye Klinikleri" has no direct and/or indirect responsibility for any damage a third party suffered or will suffer regarding "USER"s actions on the "SITE" against the rules of the hereby "Terms of Use" and the law.

4.5. "USER"s accept and undertake that the information and context they provided to the "SITE" are accurate and legal. "Turkiye Klinikleri" is not liable and responsible for promising and guaranteeing the verification of the information and context transmitted to "Turkiye Klinikleri" by the "USER"s, or uploaded, changed and provided through the "SITE" by them and whether these information are safe, accurate and legal.

4.6. "USER"s agree and undertake that they will not perform any action leading to unfair competition, weakening the personal and commercial credit of "Turkiye Klinikleri" and a third party,  encroaching and attacking on personal rights within the "SITE" in accordance with the Turkish Commercial Code Law.

4.7. "Turkiye Klinikleri" reserves the right to change the services and the context within the "SITE"  anytime. "Turkiye Klinikleri" may use this right without any notification and timelessly. "USER"s have to make the changes and/or corrections "Turkiye Klinikleri" required immediately. Any changes and/or corrections that are required by "Turkiye Klinikleri", may be made by "Turkiye Klinikleri" when needed. Any harm, criminal and civil liability resulted or will result from changes and/or corrections required by "Turkiye Klinikleri" and were not made on time by the "USER"s belongs completely to the users.

4.8. "Turkiye Klinikleri" may give links through the "SITE" to other websites and/or "CONTEXT"s and/or folders that are outside of their control and owned and run by third parties. These links are provided for ease of reference only and do not hold qualification for support the respective web SITE or the admin or declaration or guarantee for the information inside. "Turkiye Klinikleri" does not hold any responsibility over the web-sites connected through the links on the "SITE", folders and context, the services or products on the websites provided through these links or their context.

4.9. "Turkiye Klinikleri" may use the information provided to them by the "USERS" through the "SITE" in line with the terms of the "PRIVACY POLICY" and "USER CONTRACT". It may process the information or classify and save them on a database. "Turkiye Klinikleri" may also use the USER's or visitor's identity, address, e-mail address, phone number, IP number, which sections of the "SITE" they visited, domain type, browser type, date and time information to provide statistical evaluation and customized services.

5. PROPRIETARY RIGHTS

5.1. The information accessed through this "SITE" or provided by the users legally and all the elements (including but not limited to design, text, image, html code and other codes) of the "SITE" (all of them will be called as studies tied to "Turkiye Klinikleri"s copyrights) belongs to "Turkiye Klinikleri". Users do not have the right to resell, process, share, distribute, display or give someone permission to access or to use the "Turkiye Klinikleri" services, "Turkiye Klinikleri" information and the products under copyright protection by "Turkiye Klinikleri". Within hereby "Terms of Use" unless explicitly permitted by "Turkiye Klinikleri" nobody can reproduce, process, distribute or produce or prepare any study from those under "Turkiye Klinikleri" copyright protection.

5.2. Within hereby "Terms of Use", "Turkiye Klinikleri" reserves the rights for "Turkiye Klinikleri" services, "Turkiye Klinikleri" information, the products associated with "Turkiye Klinikleri" copyrights, "Turkiye Klinikleri" trademarks, "Turkiye Klinikleri" trade looks or its all rights for other entity and information it has through this website unless it is explicitly authorized by "Turkiye Klinikleri".

6. CHANGES IN THE TERMS OF USE

"Turkiye Klinikleri" in its sole discretion may change the hereby "Terms of Use" anytime announcing within the "SITE". The changed terms of the hereby "Terms of Use" will become valid when they are announced. Hereby "Terms of Use" cannot be changed by unilateral declarations of users.

7. FORCE MAJEURE

"Turkiye Klinikleri" is not responsible for executing late or never of this hereby "Terms of Use", privacy policy and "USER Contract" in any situation legally taken into account as force majeure. Being late or failure of performance or non-defaulting of this and similar cases like this will not be the case from the viewpoint of "Turkiye Klinikleri", and "Turkiye Klinikleri" will not have any damage liability for these situations. "Force majeure" term will be regarded as outside of the concerned party's reasonable control and any situation that "Turkiye Klinikleri" cannot prevent even though it shows due diligence. Also, force majeure situations include but not limited to natural disasters, rebellion, war, strike, communication problems, infrastructure and internet failure, power cut and bad weather conditions.

8. LAW AND AUTHORISATION TO FOLLOW

Turkish Law will be applied in practicing, interpreting the hereby "Terms of Use" and managing the emerging legal relationships within this "Terms of Use" in case of finding element of foreignness, except for the rules of Turkish conflict of laws. Ankara Courts and Enforcement Offices are entitled in any controversy happened or may happen due to hereby contract.

9. CLOSING AND AGREEMENT

Hereby "Terms of Use" come into force when announced in the "SITE" by "Turkiye Klinikleri". The users are regarded to agree to hereby contract terms by using the "SITE". "Turkiye Klinikleri" may change the contract terms and the changes will be come into force by specifying the version number and the date of change on time it is published in the "SITE".

 

30.03.2014

Privacy Policy

We recommend you to read the terms of use below before you visit our website. In case you agree these terms, following our rules will be to your favor. Please read our Terms of Use thoroughly.

www.turkiyeklinikleri.com website belongs to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. and is designed in order to inform physicians in the field of health

www.turkiyeklinikleri.com cannot reach to user’s identity, address, service providers or other information. The users may send this information to the website through forms if they would like to. However, www.turkiyeklinikleri.com may collect your hardware and software information. The information consists of your IP address, browser type, operating system, domain name, access time, and related websites. www.turkiyeklinikleri.com cannot sell the provided user information (your name, e-mail address, home and work address, phone number) to the third parties, publish it publicly, or keep it in the website. Gathered information has a directing feature to be a source for the website’s visitor profile, reporting and promotion of the services.

www.turkiyeklinikleri.com uses the taken information:

-To enhance, improve and maintain the quality of the website

-To generate visitor’s profile and statistical data

-To determine the tendency of the visitors on using our website

-To send print publications/correspondences

-To send press releases or notifications through e-mail

-To generate a list for an event or competition

By using www.turkiyeklinikleri.com you are considered to agree that;

-Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. cannot be hold responsible for any user’s illegal and immoral behavior,

-Terms of use may change from time to time,

-It is not responsible for other websites’ contents it cannot control or the harms they may cause although it uses the connection they provided.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. may block the website to users in the following events:

-Information with wrong, incomplete, deceiving or immoral expressions is recorded to the website,

-Proclamation, advertisement, announcement, libelous expressions are used against natural person or legal identity,

-During various attacks to the website,

-Disruption of the website because of a virus.

Written, visual and audible materials of the website, including the code and the software are under protection by legal legislation.

Without the written consent of Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. the information on the website cannot be downloaded, changed, reproduced, copied, republished, posted or distributed.

All rights of the software and the design of the website belong to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. will be pleased to hear your comments about our terms of use. Please share the subjects you think may enrich our website or if there is any problem regarding our website.

info@turkiyeklinikleri.com